ALS / Amyotrophic Lateral Sclerosis care technology platforms are the digital infrastructure underpinning modern management of the most common and most rapidly fatal adult motor neuron disease — a relentlessly progressive neurodegenerative condition caused by simultaneous upper and lower motor neuron degeneration affecting voluntary movement, speech, swallowing, and ultimately respiratory function, with genetic subtypes including SOD1 mutations (the first identified, responsible for approximately 20% of familial ALS), C9orf72 hexanucleotide repeat expansions (accounting for 40% of familial and 5–10% of sporadic cases, and uniquely associated with frontotemporal dementia overlap), TDP-43 pathology (the pathological hallmark of most ALS regardless of genetics), and FUS mutations (particularly associated with young-onset rapidly progressive disease), integrated across respiratory monitoring and ventilatory support coordination platforms, bulbar function and dysphagia surveillance systems, motor neuron disease progression dashboards, augmentative and alternative communication device management infrastructure, nutritional status and PEG feeding tube coordination tools, riluzole and edaravone pharmacotherapy management platforms, respiratory deterioration alerting systems, frontotemporal dementia and cognitive monitoring infrastructure for the 15–50% of ALS patients with cognitive impairment, palliative care and advance directive coordination systems, genetic counseling and familial risk management platforms, and multidisciplinary ALS clinic coordination infrastructure that enables neurologists, pulmonologists, respiratory therapists, speech-language pathologists, occupational therapists, dietitians, physiotherapists, genetic counselors, neuropsychologists, and palliative care specialists to detect respiratory decline, bulbar deterioration, nutritional compromise, and cognitive impairment before they produce catastrophic loss of the communication, breathing, and swallowing function that ALS patients depend on their care platforms to continuously monitor and protect. When an ALS care platform is unavailable or degraded, multidisciplinary teams cannot access the forced vital capacity trajectories, bulbar symptom severity trends, swallowing safety assessments, nutritional intake records, augmentative communication device settings, riluzole adherence data, respiratory support parameters, cognitive assessment scores, and advance directive status that guide integrated management of a disease where median survival from symptom onset is only 2–5 years and each monitoring interval matters because respiratory failure — the cause of death in over 80% of ALS patients — does not announce itself with adequate warning unless continuous digital surveillance captures the vital capacity decline, sleep-disordered breathing emergence, nocturnal desaturation patterns, and peak cough flow reduction that precede acute respiratory crisis. ALS is caused by the selective degeneration of upper motor neurons in the motor cortex — producing spasticity, hyperreflexia, and pathological reflexes — combined with lower motor neuron degeneration in the anterior horn of the spinal cord and brainstem motor nuclei — producing fasciculations, muscle wasting, weakness, and areflexia — across a disease course that is phenotypically variable in onset site (limb-onset in approximately 70%, bulbar-onset in 25%, and respiratory-onset in 5%), progression rate (bulbar-onset and respiratory-onset generally faster than limb-onset), and genetic background (C9orf72-associated ALS frequently presenting with frontotemporal dementia overlap that profoundly complicates advance care planning and substitute decision-making). The disease progresses relentlessly from initial focal weakness to global motor paralysis, respiratory failure, and death, with the trajectory heavily influenced by whether respiratory surveillance detects the decline early enough to introduce non-invasive ventilation at the optimal point — typically when forced vital capacity drops below 50–80% predicted or nocturnal desaturation emerges — where ventilatory support both prolongs survival and preserves quality of life without imposing prolonged mechanical ventilation on patients who have not had the opportunity to make an informed, capacitated advance directive about invasive ventilation. The platforms that track respiratory function trajectories, bulbar symptom progression, nutritional adequacy, augmentative communication device efficacy, cognitive status, riluzole pharmacotherapy, and palliative care coordination across a 2–5 year disease course that spans from initial diagnosis to respiratory dependency and death must remain continuously available — because missed respiratory decline alerts, undetected swallowing deterioration, inadequate nutritional surveillance, delayed augmentative communication assessment, and untimely advance directive conversations all represent preventable catastrophes in a disease where the difference between optimal and suboptimal care is measured in months of meaningful communication-preserved survival, family coordination capacity, and the dignity of a death that reflects the patient's own values rather than a respiratory crisis that occurred because monitoring platforms failed when they were needed most.
This guide covers what ALS care technology platforms need to monitor, why continuous availability matters across the full clinical spectrum of amyotrophic lateral sclerosis, and how to build a monitoring strategy that protects respiratory surveillance, bulbar function monitoring, nutritional management, augmentative communication coordination, cognitive assessment, pharmacotherapy management, and the multidisciplinary workflows that ALS care requires.
Why ALS / Amyotrophic Lateral Sclerosis Care Tech Platforms Cannot Afford Downtime
ALS management is built on five pillars: respiratory monitoring and ventilatory support coordination maintaining continuous surveillance of forced vital capacity, peak cough flow, nocturnal oxygenation, and ventilator-patient synchrony with the clinical precision that ALS-related respiratory failure requires; bulbar function and swallowing safety surveillance tracking the progressive dysphagia, dysarthria, and secretion management challenges that characterize bulbar-onset and advancing limb-onset ALS; nutritional status management and PEG coordination ensuring that declining oral intake is detected early and percutaneous endoscopic gastrostomy is offered before severe respiratory compromise makes the procedure unsafe; augmentative and alternative communication device assessment and optimization preserving functional communication capacity across the motor progression that strips away speech, handwriting, and eventually eye-gaze interface mobility; and cognitive and behavioral monitoring for frontotemporal dementia overlap, riluzole pharmacotherapy management, and advance directive coordination ensuring that the critical conversations about invasive ventilation, tracheostomy, and end-of-life care occur while the patient retains the cognitive capacity to participate. The platforms that support ALS programs must remain continuously available — because an unmonitored patient whose vital capacity has declined below the threshold for non-invasive ventilation introduction without clinical detection, whose swallowing has deteriorated to unsafe aspiration risk without dysphagia management escalation, or whose cognitive capacity has declined to substitute decision-making territory without a completed advance directive, represents a preventable cascade of harm that timely digital monitoring could have intercepted.
Respiratory monitoring is the most medically urgent clinical domain in ALS and the determinant of survival duration and quality. Respiratory failure is the cause of death in over 80% of ALS patients; the decision to initiate non-invasive ventilation — optimal when forced vital capacity is between 50–80% predicted, before respiratory decompensation occurs — is the single most survival-prolonging intervention in ALS, extending median survival by 4–7 months and improving quality of life across the remaining disease course; delay in NIV introduction because of inadequate forced vital capacity monitoring or failed respiratory threshold alerting means patients are denied months of meaningful survival and the time needed for advance directive completion, communication device optimization, and family care preparation. Forced vital capacity trajectory monitoring, peak cough flow serial measurement, nocturnal oxygenation and capnography surveillance, sleep study coordination, ventilator parameter review, and respiratory deterioration escalation alert generation must be maintained continuously in digital platforms across all hours; respiratory platform failures that allow vital capacity decline below NIV threshold without clinical detection permit preventable respiratory crisis in patients who would have benefited from earlier ventilatory support introduction.
Bulbar function and dysphagia surveillance drives the most time-sensitive nutritional and communication interventions in ALS. Bulbar-onset ALS — beginning with dysarthria, dysphagia, hypersalivation, and tongue fasciculations — progresses to severe swallowing impairment that creates aspiration risk, nutritional deficit, and the social isolation of lost communication capacity; dysphagia management requires serial videofluoroscopic swallowing study coordination, dietary modification documentation, secretion management and suctioning planning, and timing of PEG referral before respiratory function declines below the safe procedural threshold for gastrostomy; communication progression requires serial augmentative communication assessment to introduce eye-gaze devices, speech-generating devices, and partner-assisted scanning communication systems at the moment when each technology becomes necessary for functional communication. Bulbar surveillance platform failures that prevent dysphagia severity tracking or PEG referral timing alerts allow patients to reach unsafe swallowing severity without established enteral nutrition, creating acute nutritional crisis and aspiration pneumonia risk.
Nutritional management and PEG coordination requires continuous assessment of intake adequacy and procedural timing. ALS-related weight loss — driven by dysphagia, upper limb weakness affecting self-feeding, hypermetabolism, and increased caloric expenditure from respiratory effort — is an independent predictor of worse survival; PEG placement before forced vital capacity falls below 50% predicted offers the safest procedural window, but the window closes as respiratory function declines, and coordination requires simultaneous monitoring of nutritional intake adequacy, weight trajectory, PEG referral timing against respiratory function trajectory, and post-PEG feeding tolerance. Nutritional platform failures that allow weight loss to progress without enteral nutrition escalation alerts, or that fail to flag deteriorating respiratory function against PEG procedural timing windows, allow patients to reach unsafe procedural eligibility without established gastrostomy access.
Augmentative and alternative communication device management is the irreversible-loss domain of ALS. Speech in ALS is lost progressively and irreversibly; the window for banking speech samples for voice synthesis, training on symbol-based AAC systems, transitioning to eye-gaze devices, and establishing consistent communication methods with care partners and family is narrow and depends on the speech-language pathologist and assistive technology teams receiving timely motor function progression data to anticipate communication transitions before each successive modality becomes unavailable. AAC device management platform failures that prevent speech-language pathology coordination or delay eye-gaze device introduction allow patients to reach communication modality loss without established alternative systems — an irreversible loss that cannot be recovered when platforms are later restored.
Cognitive and behavioral monitoring for C9orf72-associated frontotemporal dementia overlap and advance directive management requires continuous cognitive surveillance. C9orf72 hexanucleotide repeat expansion — the most common ALS genetic variant — is uniquely associated with frontotemporal dementia in up to 50% of affected individuals; cognitive impairment in ALS, whether full FTD or the milder executive dysfunction found in 15–35% of all ALS patients regardless of genetics, profoundly complicates advance directive completion, substitute decision-making, medication adherence, and family communication; detecting cognitive decline early enough to engage patients in advance care planning before capacity is lost is among the highest-stakes time-sensitive tasks in ALS management. Cognitive monitoring platform failures that prevent frontotemporal cognitive screening, executive function trend tracking, or advance directive completion status updates allow patients to reach cognitive incapacity without documenting their wishes about invasive ventilation, tracheostomy, and end-of-life care — creating ethically and legally complex acute management situations.
What to Monitor on an ALS / Amyotrophic Lateral Sclerosis Care Tech Platform
Respiratory Monitoring and Ventilatory Support Coordination Platform
The respiratory monitoring and ventilatory support coordination service — integrating forced vital capacity serial measurement and trajectory trend monitoring, peak cough flow quantification and threshold alerting, nocturnal oxygenation pulse oximetry and capnography surveillance, sleep study result integration and sleep-disordered breathing detection, non-invasive ventilator parameter and compliance monitoring, invasive ventilator and tracheostomy management coordination for patients on long-term mechanical ventilation, respiratory deterioration threshold alerting with pre-defined clinical escalation protocols, and pulmonology and respiratory therapy scheduling coordination — is the highest-priority monitoring target. Check at a 1-minute interval with immediate escalation. Respiratory platform failures that allow forced vital capacity decline below the NIV introduction threshold without clinical detection permit preventable respiratory crisis in patients whose lives could have been meaningfully extended by timely ventilatory support; ventilator parameter monitoring failures that prevent detection of patient-ventilator dyssynchrony allow respiratory distress to develop during the nighttime hours when monitoring intensity is reduced.
Bulbar Function and Dysphagia Surveillance Platform
Monitor the bulbar function and dysphagia surveillance service — including dysarthria severity and speech intelligibility trend tracking, dysphagia symptom severity score longitudinal monitoring, videofluoroscopic swallowing study scheduling coordination and result integration, dietary modification documentation and texture level compliance, hypersalivation and secretion management protocol coordination, PEG referral timing alert generation against forced vital capacity trajectory, tracheostomy suctioning protocol management for invasively ventilated patients, and speech-language pathology assessment scheduling — at a 1-minute interval. Bulbar platform failures that prevent dysphagia severity tracking or delay PEG referral alerts allow patients to reach unsafe swallowing severity and aspiration pneumonia risk without established enteral nutrition; dysarthria monitoring failures prevent timely AAC intervention by denying speech-language pathologists the progression data needed to anticipate communication transitions.
Augmentative and Alternative Communication Device Management Platform
Monitor the AAC device management and communication support service — including speech intelligibility and communication efficiency serial assessment, speech sample banking coordination for voice synthesis before dysarthria is severe, AAC device trial and selection coordination with assistive technology specialists, eye-gaze device setup and calibration management, partner-assisted scanning training coordination, communication board and symbol set optimization, device loan and provision tracking, and communication transition planning alert generation for motor deterioration thresholds — at a 1-minute interval. AAC platform failures deny speech-language pathologists the motor progression data and device status information needed to coordinate communication transitions at the precise moment each technology becomes necessary; the irreversibility of speech loss in ALS makes AAC platform availability a continuous patient safety obligation.
Nutritional Status and PEG Feeding Management Platform
Monitor the nutritional status and PEG feeding management service — including weight trajectory longitudinal monitoring, oral intake quantification and caloric adequacy assessment, PEG referral and procedural eligibility window tracking against respiratory function data, PEG tube site management and complication monitoring, enteral feeding formula tolerance and gastrointestinal tolerance documentation, percutaneous radiological gastrostomy coordination for patients who have missed the PEG window, dietitian assessment scheduling, hypermetabolism and increased caloric need management, and nutritional decline threshold alert generation — at a 1-minute interval. Nutritional monitoring failures that allow weight loss to progress without enteral nutrition escalation alerts permit ALS-related malnutrition to compound the survival impact of motor neuron degeneration; PEG timing platform failures that fail to flag deteriorating forced vital capacity against gastrostomy procedural timing windows allow the procedural window to close without established enteral access.
Riluzole and Edaravone Pharmacotherapy Management Platform
Monitor the riluzole and edaravone pharmacotherapy management service — including riluzole hepatic function monitoring with ALT/AST trend tracking, riluzole neutropenia surveillance through regular full blood count monitoring, riluzole adherence and tolerability tracking with nausea and fatigue adverse effect documentation, edaravone infusion scheduling and cycle management for eligible patients, pharmacotherapy adverse effect escalation alert generation, and neurologist pharmacological review coordination — at a 1-minute interval. Riluzole — the first-line ALS disease-modifying therapy — reduces the rate of respiratory function decline and extends median survival by approximately 2–3 months; hepatic monitoring is required because riluzole can cause hepatotoxicity requiring dose adjustment or discontinuation, and monitoring failures that allow ALT/AST elevation without clinical detection permit drug-induced liver injury to develop in patients whose survival benefit from riluzole depends on continued safe use.
ALS Functional Rating Scale and Motor Progression Dashboard
Monitor the ALSFRS-R and motor progression tracking service — including ALS Functional Rating Scale — Revised serial score calculation and domain-specific trend analysis, motor progression rate calculation enabling survival modeling, upper motor neuron and lower motor neuron sign documentation, functional milestone tracking for ambulation, self-care, and communication, fall risk assessment integration, wheelchair and assistive equipment prescription coordination, and neurologist and multidisciplinary team escalation alert generation for accelerated decline — at a 1-minute interval. ALSFRS-R monitoring platforms provide the longitudinal motor function data that drives the timing of physiotherapy escalation, wheelchair provision, home adaptation, and disease-specific advance care planning conversations; functional progression monitoring failures prevent the early identification of rapid progressors who need more urgent respiratory surveillance intensification and advance directive coordination.
Cognitive and Behavioral Assessment Platform for FTD Overlap
Monitor the cognitive and behavioral assessment service for frontotemporal dementia overlap — including Edinburgh Cognitive and Behavioural ALS Screen serial administration and trend tracking, executive function and verbal fluency assessment coordination, behavioral and personality change monitoring for FTD-specific features including disinhibition and compulsive behavior, capacity assessment documentation and legal coordination for advance directive completion, substitute decision-maker identification and engagement, neuropsychology assessment scheduling, and cognitive decline threshold alert generation requiring advance directive urgency escalation — at a 1-minute interval. Cognitive monitoring is uniquely urgent in C9orf72-associated ALS where frontotemporal dementia may precede or accompany motor neuron disease and where advance directive completion must occur early in the disease course before cognitive capacity for these critical decisions is compromised; cognitive monitoring platform failures that allow cognitive decline without clinical capture deny patients the opportunity to document their wishes about invasive ventilation and end-of-life care while they retain capacity.
Advance Directive and Palliative Care Coordination Platform
Monitor the advance directive and palliative care coordination service — including advance directive completion status tracking and documentation, ventilatory preference discussion record maintenance (NIV-only, tracheostomy, or comfort-directed respiratory management), hospice and palliative care referral coordination, palliative care assessment scheduling, goals of care conversation documentation, end-of-life care preference record management, do-not-resuscitate order status tracking, and advance care planning completion threshold alert generation — at a 1-minute interval. Advance directive coordination in ALS is time-critical because respiratory decline can be rapid and because the conversations about invasive ventilation, tracheostomy, and hospice-level care must occur while patients retain the cognitive capacity, communication ability, and psychological readiness to participate; advance care planning platform failures that prevent directive completion tracking or delay palliative care referral allow patients to reach respiratory dependency without documented preferences for their care.
Genetic Counseling and Familial Risk Management Platform
Monitor the genetic counseling and familial risk management service — including SOD1, C9orf72, TDP-43, FUS and other pathogenic variant documentation, first-degree relative cascade genetic testing coordination, pre-symptomatic genetic counseling appointment management, genetic result disclosure support coordination, familial ALS registry maintenance, reproductive counseling and preimplantation genetic diagnosis coordination for reproductive-age family members, and clinical trial eligibility screening based on genetic subtype for emerging gene-specific therapies — at a 2-minute interval. Genetic platform failures that prevent cascade testing coordination or clinical trial eligibility screening based on genetic subtype deny family members the opportunity for pre-symptomatic surveillance enrollment and deny patients access to the antisense oligonucleotide therapies (such as SOD1-targeting tofersen) whose eligibility depends on confirmed genetic subtype documentation maintained in care platforms.
Physiotherapy and Assistive Technology Coordination Platform
Monitor the physiotherapy and assistive technology coordination service — including physiotherapy session scheduling for spasticity management, range of motion maintenance, and fatigue-adapted exercise, wheelchair assessment and provision coordination, powered wheelchair interface and joystick adaptation management for progressive upper limb weakness, home adaptation assessment and occupational therapy coordination, falls risk assessment integration, splinting and contracture prevention coordination, and functional decline threshold alert generation for equipment escalation — at a 1-minute interval. Physiotherapy coordination in ALS requires continuous adaptation to progressive motor decline; spasticity management, wheelchair optimization, and home adaptation coordination platform failures create functional losses and safety risks in patients whose motor disability is advancing continuously.
Telemedicine and Multidisciplinary ALS Clinic Coordination Platform
Monitor the telemedicine session API, multidisciplinary ALS clinic scheduling platform, specialist coordination infrastructure for neurology, pulmonology, speech pathology, dietetics, physiotherapy, occupational therapy, genetic counseling, neuropsychology, social work, and palliative care, remote respiratory assessment and spirometry result transmission infrastructure, and caregiver support coordination system at a 2-minute interval. ALS management requires simultaneous coordination across ten or more clinical disciplines within a care model where the clinic visit frequency must be calibrated to progression rate; multidisciplinary coordination platform failures interrupt the integrated assessments that allow respiratory, bulbar, nutritional, communication, motor, cognitive, and psychosocial domains to be addressed comprehensively within a disease course where missed clinic intervals can produce irreversible losses.
EHR Synchronization Endpoint
Monitor the EHR synchronization service at a 5-minute interval. ALS patients presenting to emergency departments with acute respiratory failure, aspiration pneumonia, or sudden communication loss require immediate provider access to their current forced vital capacity trend, ventilatory support parameters, advance directive and ventilation preferences, current medications including riluzole and edaravone, nutritional support configuration, communication device settings, and emergency contact details to guide safe acute management without default invasive ventilation in patients who have documented comfort-directed preferences.
Authentication Service
Monitor authentication at a 1-minute interval. Auth failures lock neurologists, pulmonologists, respiratory therapists, speech-language pathologists, dietitians, physiotherapists, occupational therapists, neuropsychologists, genetic counselors, and palliative care specialists out of respiratory monitoring systems, bulbar surveillance platforms, AAC management tools, nutritional dashboards, and advance directive coordination infrastructure simultaneously — disabling the entire ALS digital management infrastructure at a stroke when clinical teams most need it.
SSL Certificates Across All Platform Domains
Monitor certificate expiry 30 days in advance across all patient-facing, clinician-facing, and integration domains. Certificate failures block patient portal access to respiratory monitoring data, the AAC device management systems used by communication-impaired patients with limited redundant access modalities, and the advance care planning platforms that facilitate the critical conversations about ventilatory preferences that ALS patients must complete while they retain capacity.
Alerting Strategy for ALS / Amyotrophic Lateral Sclerosis Care Tech Platforms
Immediate clinical escalation (24/7): Respiratory monitoring and ventilatory support coordination platform, bulbar function and dysphagia surveillance platform, AAC device management platform, nutritional status and PEG feeding management platform, riluzole and edaravone pharmacotherapy management platform, ALSFRS-R and motor progression dashboard, cognitive and behavioral assessment platform, advance directive and palliative care coordination platform, physiotherapy and assistive technology coordination platform, authentication service. These affect real-time respiratory surveillance, bulbar safety monitoring, communication device continuity, nutritional management, pharmacotherapy oversight, motor progression tracking, cognitive capacity monitoring, and advance directive coordination continuously.
Immediate clinical operations escalation: Genetic counseling and familial risk management platform. Failures here affect cascade genetic testing coordination and clinical trial eligibility screening based on genetic subtype that have time-sensitive implications for family members and for gene-specific therapy access.
High-priority immediate escalation: Telemedicine and multidisciplinary ALS clinic coordination platform. Access failures interrupt the multidisciplinary coordination across ten or more clinical disciplines that ALS care requires.
Business-hours engineering escalation: EHR synchronization. Investigate within one business hour.
Advance warning: SSL certificate expiry, 30 days in advance, across all patient-facing and integration domains.
Respiratory monitoring and advance directive coordination require 24/7 alerting because ALS-related respiratory failure does not respect business hours — nocturnal hypoventilation begins during sleep, respiratory decompensation can develop rapidly, and the ventilatory support decisions that must be coordinated through digital platforms become emergencies when they occur without advance preparation. Cognitive monitoring requires urgent coverage because the window for capacitated advance directive completion closes without warning as frontotemporal dementia progresses, and platform failures during that window produce irreversible gaps in documented patient preferences.
Status Page as a Clinical Safety Signal
Neurology nurses and ALS care coordinators managing after-hours contacts from patients reporting acute respiratory distress, acute dysphagia events, AAC device failures, or emergency nutritional tube complications need immediate platform status awareness before initiating escalation protocols. A published status page allows on-call coordinators to distinguish a platform incident from connectivity problems — and to activate manual respiratory monitoring protocols, phone-based clinical assessment, emergency respiratory team escalation, and emergency clinical routing immediately when the digital platform is confirmed unavailable.
For ALS programs coordinating multidisciplinary monitoring across respiratory, bulbar, nutritional, communication, cognitive, and palliative domains in a disease with median survival of only 2–5 years where each monitoring interval matters, a status page enables rapid identification of platform failures and activation of manual monitoring and escalation protocols. Publish the status page URL in care coordinator workstations, on-call neurology and pulmonology systems, respiratory therapy nursing dashboards, speech-language pathology scheduling tools, palliative care coordination systems, and caregiver emergency contact platforms.
The Business Case: Respiratory Safety, Communication Preservation, and ALS Program Quality
ALS specialty programs face significant cost exposure from preventable respiratory crisis from undetected vital capacity decline below NIV threshold, aspiration pneumonia from unmonitored dysphagia progression, malnutrition from missed PEG referral timing windows, irreversible communication loss from delayed AAC device transitions, riluzole hepatotoxicity from inadequate hepatic monitoring, advance directive completion failures from cognitive decline without clinical detection, and the downstream costs of emergency respiratory management without documented ventilatory preferences — with the cumulative cost of inadequate monitoring measured in respiratory emergencies, prolonged ICU admissions for patients who did not document their ventilation preferences, preventable aspiration events, and the irreversible communication losses that occur when AAC platform failures deny speech-language pathologists the progression data needed to coordinate technology transitions. Respiratory surveillance — using continuous forced vital capacity trajectory monitoring to introduce non-invasive ventilation at the optimal clinical window — is the intervention with the greatest survival impact in ALS; advance directive coordination — using cognitive monitoring platforms to ensure capacitated ventilation preference documentation before cognitive capacity is compromised — prevents the ethical and legal complexity of substitute decision-making in acute respiratory crisis.
Missed respiratory decline alerts that allow vital capacity to fall below NIV threshold without clinical detection deprive patients of 4–7 months of meaningful survival that timely ventilatory support would have enabled. Missed bulbar surveillance that allows dysphagia to progress to aspiration pneumonia risk without PEG referral creates acute nutritional crisis and respiratory complication that appropriate monitoring prevents. Missed cognitive monitoring that allows frontotemporal dementia to progress without advance directive completion creates ethically complex end-of-life situations in patients who could have documented their ventilation preferences while they retained capacity. Missed genetic cascade coordination that fails to screen first-degree relatives denies family members access to pre-symptomatic surveillance and emerging gene-specific therapies whose window of benefit may be limited to the presymptomatic period. Platforms that accurately capture respiratory function trajectories, bulbar symptom progression, AAC device needs, nutritional adequacy, cognitive status, pharmacotherapy safety, and advance directive status enable multidisciplinary teams to coordinate the respiratory, nutritional, communication, cognitive, and palliative interventions that ALS management requires across a disease course where timing is everything.
ALS program quality metrics increasingly include NIV initiation timing relative to forced vital capacity threshold, PEG placement timing relative to respiratory function, advance directive completion rates before capacity loss, AAC device introduction timing relative to speech intelligibility decline, riluzole hepatic monitoring compliance rates, and caregiver burden assessment completion rates. Platform reliability is a direct input to outcome quality — programs whose monitoring platforms frequently fail will show delayed NIV introduction, missed PEG timing windows, advance directive completion failures, delayed AAC transitions, riluzole hepatotoxicity events, and functional losses that could have been prevented by continuous digital monitoring.
External monitoring from Vigilmon provides the documented, independent availability record that ALS program directors can present to hospital administration, motor neuron disease program leadership, payer medical directors, and regulatory bodies as evidence that the program's digital infrastructure supports the continuous respiratory surveillance, bulbar monitoring, AAC coordination, and advance directive management that amyotrophic lateral sclerosis management requires.
Vigilmon Setup for ALS / Amyotrophic Lateral Sclerosis Care Tech Platforms
A practical starting configuration:
| Monitor | Check Interval | Alert Channel | |---------|----------------|---------------| | Respiratory monitoring and ventilatory support coordination platform | 1 min | PagerDuty (immediate, 24/7) | | Bulbar function and dysphagia surveillance platform | 1 min | PagerDuty (immediate, 24/7) | | AAC device management and communication support platform | 1 min | PagerDuty (immediate, 24/7) | | Nutritional status and PEG feeding management platform | 1 min | PagerDuty (immediate, 24/7) | | Riluzole and edaravone pharmacotherapy management platform | 1 min | PagerDuty (immediate, 24/7) | | ALSFRS-R and motor progression dashboard | 1 min | PagerDuty (immediate, 24/7) | | Cognitive and behavioral assessment platform | 1 min | PagerDuty (immediate, 24/7) | | Advance directive and palliative care coordination platform | 1 min | PagerDuty (immediate, 24/7) | | Physiotherapy and assistive technology coordination platform | 1 min | PagerDuty (immediate, 24/7) | | Auth service | 1 min | PagerDuty (immediate) | | Genetic counseling and familial risk management platform | 2 min | PagerDuty (immediate, 24/7) | | Telemedicine and multidisciplinary ALS clinic coordination platform | 2 min | PagerDuty + Slack (immediate) | | EHR synchronization endpoint | 5 min | Slack (business hours) | | SSL: all platform domains | Daily | Email (30-day warning) |
Getting started:
- Create a free account at vigilmon.online
- Add the respiratory monitoring and ventilatory support coordination platform at a 1-minute interval with 24/7 PagerDuty alerting
- Add bulbar function, AAC device management, and nutritional status platforms at a 1-minute interval with immediate 24/7 escalation
- Add riluzole pharmacotherapy, ALSFRS-R progression, and cognitive assessment platforms at a 1-minute interval with immediate alerting
- Add advance directive coordination and physiotherapy platforms at a 1-minute interval with immediate 24/7 alerting
- Add genetic counseling and familial risk management at a 2-minute interval with 24/7 PagerDuty alerting
- Add telemedicine and multidisciplinary ALS clinic coordination platform with immediate alerting
- Add authentication and EHR synchronization
- Enable SSL monitoring across all patient-facing, respiratory monitoring, AAC device management, and advance directive coordination domains
- Publish the automatic status page URL in care coordinator workstations, on-call neurology and pulmonology systems, respiratory therapy nursing dashboards, speech-language pathology scheduling tools, palliative care coordination systems, and caregiver emergency contact platforms
Conclusion
ALS care tech platforms hold the clinical monitoring infrastructure that makes amyotrophic lateral sclerosis management possible across its uniquely urgent disease course — respiratory monitoring and ventilatory support coordination platforms tracking forced vital capacity trajectories against the non-invasive ventilation introduction threshold that represents the most survival-prolonging intervention in motor neuron disease, bulbar surveillance platforms monitoring dysphagia severity against the PEG referral timing window that must be captured before respiratory compromise makes gastrostomy unsafe, augmentative communication device management platforms preserving the communication capacity that progressive dysarthria would otherwise eliminate without coordinated technology transitions, nutritional management platforms tracking weight trajectory and caloric adequacy in a disease where malnutrition compounds motor neuron degeneration and independently worsens survival, pharmacotherapy management platforms ensuring riluzole hepatic safety and edaravone infusion coordination in a patient population receiving disease-modifying therapy whose benefit depends on safe continuous administration, motor progression dashboards generating the ALSFRS-R trajectory data that drives the timing of respiratory surveillance intensification, wheelchair provision, home adaptation, and advance care planning escalation, cognitive monitoring platforms detecting the frontotemporal dementia overlap that complicates advance directive completion and substitute decision-making in C9orf72-associated disease and the executive dysfunction found across ALS genetics that impairs medication adherence and care planning participation, advance directive and palliative care coordination platforms ensuring that the critical conversations about invasive ventilation, tracheostomy, and comfort-directed care occur while patients retain the cognitive capacity, communication ability, and psychological readiness to participate in their own end-of-life decisions, and genetic counseling platforms managing the cascade testing, clinical trial eligibility screening, and reproductive counseling obligations created by the inherited forms of ALS that place first-degree relatives at defined genetic risk. Their availability is a prerequisite for safe disease management and the respiratory protection, bulbar monitoring, communication preservation, nutritional support, pharmacotherapy safety, cognitive surveillance, and advance directive coordination that patients with ALS depend on throughout an illness whose 2–5 year median survival from symptom onset means that every monitoring failure, every missed respiratory threshold alert, every delayed AAC device transition, every advance directive completion missed because cognitive platforms were unavailable creates irreversible losses in a disease where there are no second chances — where the forced vital capacity that was not monitored when the platform was down does not rebound, where the speech sample not banked before dysarthria was severe cannot be recovered, where the advance directive not completed before frontotemporal dementia compromised capacity cannot be made capacitated by restoring the platform, and where the respiratory crisis that occurred because monitoring platforms failed represents not only a clinical failure but the loss of the quality, dignity, and self-determination that continuous ALS care technology monitoring is designed to preserve. When respiratory monitoring platforms go offline, bulbar surveillance systems fail, or AAC device management dashboards are unavailable, the clinical consequences extend to a disease where the difference between adequate and inadequate monitoring is measured in survival duration, communication years, nutritional status, and the quality of the death that patients with ALS deserve — a death that reflects their documented preferences, not a respiratory emergency that occurred because the platforms that should have detected the vital capacity decline, coordinated the ventilatory support discussion, and confirmed the advance directive were unavailable when they were needed most.
External monitoring from Vigilmon provides the independent, outside-in availability view that ALS program directors and health system IT teams need to catch failures before they affect respiratory surveillance, bulbar monitoring, or advance directive coordination — with the documented incident record that motor neuron disease program leadership, accreditation bodies, and payer audit teams accept as evidence of operational maturity in a program managing one of the most clinically urgent and time-sensitive rare diseases in neurological practice, where platform uptime is directly equivalent to patient survival, communication capacity, and the dignity of a death shaped by informed, capacitated advance care planning rather than monitored inadequately.
Start monitoring your ALS / Amyotrophic Lateral Sclerosis care tech platform for free at vigilmon.online — HTTP/HTTPS monitoring, multi-region consensus alerting, SSL certificate monitoring, automatic status page, Slack and PagerDuty integration. No agent required. No credit card.
Tags: #monitoring #ALS #AmyotrophicLateralSclerosis #motorNeuronDisease #SOD1 #C9orf72 #TDP43 #FUS #respiratoryFailure #NIV #bulbarOnset #ALSFRS #dysphagia #AAC #augmentativeCommunication #riluzole #edaravone #frontotemporal #advanceDirective #palliativeCare #rareDisease #neurology #healthtech #uptime #clinicaldocumentation #sre